PRP and Method of Ratios

Method of Ratios Applies to PRP Made by Commercial Device Technologies

My boss, Dr. David Karli, introduced the concept of the method of ratios during a talk he gave at the TOBI conference this past June. He wrote a couple of guest posts for the Blog in which he covered the field of hemoanalytics and how, in the case of PRP, a set of ratios might...
Read More
Amniotic Fluid-derived Information

The Astonishing Mis-information Being Shared on Amniotic Fluid-Derived Products – Part Two

I would like to finish up with my review of outrageous mis-information being spread about by some advocates of amniotic fluid-derived products. My focus has been on a Powerpoint presentation (PPt) made available to the public by Dr. Davidson. So far, I have pointed out what I contend are discrepancies in some of his statements,...
Read More
Fact Check Amniotic Fluid

The Astonishing Mis-information Being Shared on Amniotic Fluid Products – Part One

Although I recently covered amniotic products in a couple of posts (Another Amniotic-derived Product Mis-states FDA Compliance and Addressing the Flood of Placental Tissue-based HCT/P Products, Again), and thought I could escape the morass that is amniotic fluid containing products, I came across a Powerpoint presentation (PPt) offered up by Dr. Davidson (Park City, Utah) Nanofactor...
Read More
Placental Tissue-based HCT/P Products

Addressing the Flood of Placental Tissue-based HCT/P Products, Again

 In the previous post, I began a review of a marketing blurb sent to my boss, Dr. David Karli, extolling the virtues of an amniotic fluid-containing product. I am sure you are wondering why I haven’t mentioned the name of the manufacturer and the offending product, but see the explanation provided in the previous post....
Read More
Amniotic-derived Product False Claim

Another Amniotic-derived Product Mis-states FDA Compliance

During a course offered by ASIPP last March in Las Vegas, NV, I gave a brief impromptu presentation about regulatory issues in the field of translational regenerative medicine. I mentioned that producers of placental tissue-derived products, like amniotic fluid products or amniotic fluid plus micronized amniotic tissue products, were sprouting like weeds, despite the issuing...
Read More
SVF Preparation

Fuzz Balls Aren’t Equivalent to SVF in the World of Regenerative Medicine

In the previous post, I covered a material I call Fuzz Balls produced in the Lipogems System. My contention is that the Fuzz Balls can’t be used to treat orthopedic pathologies for regulatory reasons, which definitely is a minority position. I also mentioned that I had been taken to task for the somewhat tongue-in-cheek use...
Read More
Lipogems Adipose Tissue

Lipogems Not to the Rescue

The previous post provided an introduction into what’s happening in the world of fat tissue-based therapeutic preparations in the USA. I focused on the situation in which physicians use enzymatic digestion of a patient’s fat tissue to manufacture stromal vascular fraction (SVF), which is a single cell suspension containing mesenchymal stem cells (MSCs). I ended the...
Read More
1 2 3 4